In addition, considering the potential tumorigenesis risk of AF-MSCs and gene-modified IFNα-AF-MSCs, we performed further experiments to evaluate the possibility that AF-MSCs may form tumors. This evidence concerns the gene IFNA17 and atrial fibrillation.